Delivery Order SPE2DB20D9331-SPE2DB22FL0L6

Award Date 1/21/22

Potential Completion Date 1/24/22

Potential Value $8.6K

Federal Agency

Defense Logistics Agency

Awardee

DMS Pharmaceutical Group Inc. PX72BSBQTKJ3

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Park Ridge, IL 60068, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $8,643.00, is a firm fixed-price delivery order for the supply of 120 capsules of the prescription drug Xtandi 40 mg.

The contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.

Generated 1/9/25, 9:29 AM